Compare2 funds · 1 pair
Picked · 2YTD
IHEvsIXJVersus · 5Y · 25.8% held in common5–1measures won
Close to theseFee · YTD
Best of the twoNov 6
  • Lowest cost$ a year on $10kIHE 0.37%
  • Most incometrailing 12-month yieldIHE 1.34%
  • Best 5 yearsper yearIHE +13.1%
  • Smallest drop · 1Yworst fall in the past yearIHE −9.7%
Measures won5–1IHE wins · of 6 · 5Y
$10,000 · 5Y$18,497IHE · IXJ $13,862
Lowest cost0.37%IHE · $37 on $10k
Most income1.34%IHE · $134 on $10k
Smallest drop−9.7%IHE · worst fall in 1Y
Held in common25.8%IHE and IXJ

IHE vs IXJ

5Y
IHE
IXJ
iShares U.S. Pharmaceuticals ETF · $1.6BiShares Global Healthcare ETF · $4.6B
+26.1%3 years · per year$20,049 · $14,818+14.0%
+13.1%5 years · per year$18,497 · $13,862+6.7%
0.37%Expense ratio$37 · $38 on $10k · lower wins0.38%
1.34%12-mo yield$134 · $128 on $10k1.28%
−9.7%Worst dropSmaller wins−10.8%
19.1%VolatilityLower wins16.3%
5–1IHE wins
$10,000 · 5 yearsOne scale
$10k startIHE $18.5kIXJ $13.9kOct 2021Nov 2026
Shared top holdingsIHE · IXJ
26.4%LLY11.1%
22.2%JNJ6.7%
4.3%MRK4.1%
4.7%PFE1.9%
Held in common25.8%
End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1AIHEiShares U.S. Pharmaceuticals ETFReadDesk0.37%1.34%+1.0%+26.8%+41.9%+26.1%+13.1%−9.7%$1.6B
2BIXJiShares Global Healthcare ETFReadDesk0.38%1.28%+0.1%+17.0%+25.1%+14.0%+6.7%−10.8%$4.6B
End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

IHE vs IXJ

5Y
iShares U.S. Pharmaceuticals
$18,497
iShares Global Healthcare
$13,862
$10k$15kNov 2021Nov 2026$18,497$13,862$10k$15kNov 2021Nov 2026$18,497$13,862
MeasureIHEIXJ
Fee0.37%0.38%
Cost on $10k a year$37$38
Yield1.34%1.28%
5 years, per year+13.1%+6.7%
3 years, per year+26.1%+14.0%
Worst drop · 1Y−9.7%−10.8%
Volatility · 1Y19.1%16.3%
4–1measures won
IHE first
25.8%
holdings shared
Nov 6, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+31.4%
VIGVanguard
+12.1%
Jan 1Nov 6+31.4%+12.1%
+31.4%Year to date+12.1%
3.0%Yield1.5%
$120BAssets$109B
2–0SCHD wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+3.2%
JEPIJ.P. Morgan
+5.3%
Jan 1Nov 6+3.2%+5.3%
+3.2%Year to date+5.3%
12.8%Yield8.1%
$42.6BAssets$46.8B
1–1level
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+8.8%
SPYSPDR
+8.7%
Jan 1Nov 6+8.8%+8.7%
+8.8%Year to date+8.7%
1.1%Yield1.0%
$182BAssets$819B
2–0SPYM wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

Overlap: IHE, IXJ

Today
25.8%most shared, IHE and IXJ
IHEIXJ
IHE—25.8%
IXJ25.8%—
End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$97most kept, IHE
IHE$134 − $37 = $97
IXJ$128 − $38 = $90
KeptFee
End-of-day Nov 6, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com